Protein primary structure correlates with calcium oxalate stone matrix preference.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
24
05
2021
accepted:
02
09
2021
entrez:
23
9
2021
pubmed:
24
9
2021
medline:
18
11
2021
Statut:
epublish
Résumé
Despite the apparent importance of matrix proteins in calcium oxalate kidney stone formation, the complexity of the protein mixture continues to elude explanation. Based on a series of experiments, we have proposed a model where protein aggregates formed from a mixture containing both strongly charged polyanions and strongly charged polycations could initiate calcium oxalate crystal formation and crystal aggregation to create a stone. These protein aggregates also preferentially adsorb many weakly charged proteins from the urine to create a complex protein mixture that mimics the protein distributions observed in patient samples. To verify essential details of this model and identify an explanation for phase selectivity observed in weakly charged proteins, we have examined primary structures of major proteins preferring either the matrix phase or the urine phase for their contents of aspartate, glutamate, lysine and arginine; amino acids that would represent fixed charges at normal urine pH of 6-7. We verified enrichment in stone matrix of proteins with a large number of charged residues exhibiting extreme isoelectric points, both low (pI<5) and high (pI>9). We found that the many proteins with intermediate isoelectric points exhibiting preference for stone matrix contained a smaller number of charge residues, though still more total charges than the intermediate isoelectric point proteins preferring the urine phase. While other sources of charge have yet to be considered, protein preference for stone matrix appears to correlate with high total charge content.
Identifiants
pubmed: 34555074
doi: 10.1371/journal.pone.0257515
pii: PONE-D-21-15604
pmc: PMC8459966
doi:
Substances chimiques
Proteins
0
Calcium Oxalate
2612HC57YE
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0257515Subventions
Organisme : CSRD VA
ID : I01 CX001491
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK082550
Pays : United States
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Urolithiasis. 2019 Dec;47(6):521-532
pubmed: 30993355
Urol Res. 2011 Aug;39(4):269-82
pubmed: 21229239
Urolithiasis. 2017 Feb;45(1):57-74
pubmed: 27913854
Front Biosci. 2004 May 01;9:1450-82
pubmed: 14977559
Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):426-30
pubmed: 1729712
N Engl J Med. 1992 Oct 15;327(16):1141-52
pubmed: 1528210
Urolithiasis. 2021 Aug;49(4):281-290
pubmed: 33587148
Int Braz J Urol. 2013 Jan-Feb;39(1):128-36
pubmed: 23489505
Int J Urol. 2012 Aug;19(8):765-72
pubmed: 22494008
J Urol. 1956 Sep;76(3):213-27
pubmed: 13368269
Proteome Sci. 2016 Feb 27;14:4
pubmed: 26924944
Am J Physiol Renal Physiol. 2008 Oct;295(4):F1254-8
pubmed: 18701630
Proc Natl Acad Sci U S A. 2005 Jan 11;102(2):267-72
pubmed: 15625112
PLoS One. 2013 Jul 24;8(7):e69916
pubmed: 23894559
Urolithiasis. 2017 Aug;45(4):337-346
pubmed: 28314883
Eur Urol. 2012 Jul;62(1):160-5
pubmed: 22498635
Langmuir. 2012 Nov 13;28(45):15947-57
pubmed: 23083137
Adv Chronic Kidney Dis. 2009 Jan;16(1):5-10
pubmed: 19095200
Urol Res. 2005 Jun;33(3):206-12
pubmed: 15864572
Urology. 2010 Oct;76(4):1017.e13-20
pubmed: 20709378
Kidney Int. 2003 May;63(5):1817-23
pubmed: 12675858